JP2023554504A5 - - Google Patents
Info
- Publication number
- JP2023554504A5 JP2023554504A5 JP2023537585A JP2023537585A JP2023554504A5 JP 2023554504 A5 JP2023554504 A5 JP 2023554504A5 JP 2023537585 A JP2023537585 A JP 2023537585A JP 2023537585 A JP2023537585 A JP 2023537585A JP 2023554504 A5 JP2023554504 A5 JP 2023554504A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- protein
- composition according
- seq
- highly active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20214696 | 2020-12-16 | ||
| EP20214696.5 | 2020-12-16 | ||
| EP21209719 | 2021-11-22 | ||
| EP21209719.0 | 2021-11-22 | ||
| PCT/EP2021/086348 WO2022129438A1 (en) | 2020-12-16 | 2021-12-16 | Programmable transposases and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023554504A JP2023554504A (ja) | 2023-12-27 |
| JP2023554504A5 true JP2023554504A5 (https=) | 2024-12-19 |
Family
ID=79287993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537585A Pending JP2023554504A (ja) | 2020-12-16 | 2021-12-16 | プログラム可能なトランスポザーゼおよびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240052371A1 (https=) |
| EP (1) | EP4263819A1 (https=) |
| JP (1) | JP2023554504A (https=) |
| KR (1) | KR20230123492A (https=) |
| AU (1) | AU2021403660A1 (https=) |
| CA (1) | CA3202403A1 (https=) |
| IL (1) | IL303612A (https=) |
| MX (1) | MX2023007030A (https=) |
| WO (1) | WO2022129438A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116209756A (zh) | 2020-03-04 | 2023-06-02 | 旗舰先锋创新Vi有限责任公司 | 调控基因组的方法和组合物 |
| AU2022343268A1 (en) | 2021-09-08 | 2024-03-28 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| KR20250010025A (ko) | 2022-05-13 | 2025-01-20 | 인테그라 테라퓨틱스 | 도입유전자 발현 및 핵 국소화를 개선하기 위한 트랜스포사제의 용도 |
| IL324386A (en) * | 2023-05-10 | 2026-01-01 | Poseida Therapeutics Inc | Transposases and uses thereof |
| CN121443733A (zh) | 2023-06-01 | 2026-01-30 | 英特格拉治疗公司 | 转座酶及其用途 |
| CN116813800B (zh) * | 2023-07-07 | 2024-03-12 | 南京诺唯赞生物科技股份有限公司 | 一种双链dna结合蛋白-转座酶融合蛋白及文库构建方法 |
| KR20250040558A (ko) | 2023-09-15 | 2025-03-24 | 주식회사 엘지화학 | 입자 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018513681A (ja) * | 2015-03-31 | 2018-05-31 | エクセリゲン サイエンティフィック, インコーポレイテッドExeligen Scientific, Inc. | 細胞または生物のゲノムへのＤＮＡ配列の標的化組み込みのためのＣａｓ９レトロウイルスインテグラーゼおよびＣａｓ９レコンビナーゼ系 |
| WO2018175872A1 (en) * | 2017-03-24 | 2018-09-27 | President And Fellows Of Harvard College | Methods of genome engineering by nuclease-transposase fusion proteins |
| US20220235379A1 (en) | 2019-06-11 | 2022-07-28 | Universitat Pompeu Fabra | Targeted gene editing constructs and methods of using the same |
-
2021
- 2021-12-16 AU AU2021403660A patent/AU2021403660A1/en active Pending
- 2021-12-16 JP JP2023537585A patent/JP2023554504A/ja active Pending
- 2021-12-16 WO PCT/EP2021/086348 patent/WO2022129438A1/en not_active Ceased
- 2021-12-16 KR KR1020237023944A patent/KR20230123492A/ko active Pending
- 2021-12-16 MX MX2023007030A patent/MX2023007030A/es unknown
- 2021-12-16 US US18/258,039 patent/US20240052371A1/en active Pending
- 2021-12-16 IL IL303612A patent/IL303612A/en unknown
- 2021-12-16 CA CA3202403A patent/CA3202403A1/en active Pending
- 2021-12-16 EP EP21839989.7A patent/EP4263819A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023554504A5 (https=) | ||
| US12173284B2 (en) | Modified guide RNAs | |
| JP7094323B2 (ja) | 最適化機能ＣＲＩＳＰＲ－Ｃａｓ系による配列操作のための系、方法および組成物 | |
| JP7093728B2 (ja) | 化学的に修飾されたガイドｒｎａを使用する高特異性ゲノム編集 | |
| AU2014361834B2 (en) | CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes | |
| US12509492B2 (en) | Genome engineering with CRISPR-Cas systems in eukaryotes | |
| US11421218B2 (en) | Methods for enhancing the efficiency of gene editing | |
| US20230212615A1 (en) | Grna targeting ctgf gene and use thereof | |
| JP2024502348A (ja) | Ｔｒａｃｒ不含 Ｖ型Ｃａｓシステム用のガイドＲＮＡデザインおよび複合体 | |
| Chen et al. | Functions of heterogeneous nuclear ribonucleoproteins in stem cell potency and differentiation | |
| KR20220112698A (ko) | 교정 효율이 개선된 프라임에디팅용 조성물 | |
| Li et al. | Site-directed RNA editing by harnessing ADARs: advances and challenges | |
| CN117959446A (zh) | miR-103-3p在调控鸡卵泡发育中的应用 | |
| JP2024515113A (ja) | 重篤な疾患を処置するためのｂ細胞ベースのタンパク質工場の操作 | |
| JP2020513849A5 (https=) | ||
| US20240309347A1 (en) | Fusion Proteins for CRISPR-based Transcriptional Repression | |
| JP2023515681A (ja) | 線維症を予防するための線維芽細胞の活性化調節 | |
| JP2025516484A5 (https=) | ||
| JP2025518638A5 (https=) | ||
| WO2025080959A1 (en) | Compositions and methods for treating pulmonary arterial hypertension | |
| JP2025518638A (ja) | 導入遺伝子の発現および核局在化を改善するためのトランスポザーゼの使用 | |
| Halmai | Epigenetic Editing of the X-Linked Intellectual Disability Genes CDKL5 and MECP2 | |
| HK40107754A (zh) | 工程改造基於b细胞的蛋白质工厂以治疗严重疾病 | |
| CN121358852A (zh) | 紧凑蛋白 | |
| JP2023031025A (ja) | 小胞分泌制御剤および小胞取り込み制御剤 |